SE8803087D0 - A new method of treating erectile dysfunction - Google Patents

A new method of treating erectile dysfunction

Info

Publication number
SE8803087D0
SE8803087D0 SE8803087A SE8803087A SE8803087D0 SE 8803087 D0 SE8803087 D0 SE 8803087D0 SE 8803087 A SE8803087 A SE 8803087A SE 8803087 A SE8803087 A SE 8803087A SE 8803087 D0 SE8803087 D0 SE 8803087D0
Authority
SE
Sweden
Prior art keywords
new method
erectile dysfunction
treating erectile
optionally
treating
Prior art date
Application number
SE8803087A
Other languages
English (en)
Other versions
SE8803087L (sv
SE463851B (sv
Inventor
Nils G Kock
Gerhard Lycke
Original Assignee
Nils G Kock
Gerhard Lycke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20373202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8803087(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nils G Kock, Gerhard Lycke filed Critical Nils G Kock
Priority to SE8803087A priority Critical patent/SE463851B/sv
Publication of SE8803087D0 publication Critical patent/SE8803087D0/sv
Priority to IE268089A priority patent/IE62587B1/en
Priority to NZ230400A priority patent/NZ230400A/xx
Priority to ZA896681A priority patent/ZA896681B/xx
Priority to ES89850282T priority patent/ES2055677T5/es
Priority to EP89850282A priority patent/EP0357581B2/en
Priority to JP1509519A priority patent/JPH0791199B2/ja
Priority to PCT/SE1989/000462 priority patent/WO1990002545A1/en
Priority to EP89909891A priority patent/EP0432199B2/en
Priority to AT89909891T priority patent/ATE91886T1/de
Priority to CA000610172A priority patent/CA1335346C/en
Priority to AU41994/89A priority patent/AU638414B2/en
Priority to DE68907909T priority patent/DE68907909T3/de
Publication of SE8803087L publication Critical patent/SE8803087L/sv
Publication of SE463851B publication Critical patent/SE463851B/sv
Priority to FI910976A priority patent/FI102454B/sv
Priority to DK199100364A priority patent/DK175560B1/da
Priority to NO910828A priority patent/NO301046B1/no
Priority to GR90300093T priority patent/GR900300093T1/el
Priority to US08/485,041 priority patent/US5886039A/en
Priority to US08/481,609 priority patent/US5942512A/en
Priority to US08/484,546 priority patent/US5843961A/en
Priority to US08/478,982 priority patent/US5849803A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE8803087A 1988-09-02 1988-09-02 Komposition foer behandling av erektil dysfunktion via uretra SE463851B (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE8803087A SE463851B (sv) 1988-09-02 1988-09-02 Komposition foer behandling av erektil dysfunktion via uretra
IE268089A IE62587B1 (en) 1988-09-02 1989-08-21 Composition for the treatment of erectile dysfunction
NZ230400A NZ230400A (en) 1988-09-02 1989-08-22 Phentolamine and hydrophilic vehicle for use in treating erectile dysfunction
ZA896681A ZA896681B (en) 1988-09-02 1989-08-31 A composition for the treatment of erectile dysfunction
ES89850282T ES2055677T5 (es) 1988-09-02 1989-08-31 Composicion para el tratamiento de la disfuncion erectil.
EP89850282A EP0357581B2 (en) 1988-09-02 1989-08-31 Composition for the treatment of erectile dysfunction
DE68907909T DE68907909T3 (de) 1988-09-02 1989-09-01 Präparat zur behandlung von erektionsstörungen.
PCT/SE1989/000462 WO1990002545A1 (en) 1988-09-02 1989-09-01 Composition for the treatment of erectile dysfunction
AT89909891T ATE91886T1 (de) 1988-09-02 1989-09-01 Praeparat zur behandlung von erektionsstoerungen.
AU41994/89A AU638414B2 (en) 1988-09-02 1989-09-01 Composition for the treatment of erectile dysfunction
EP89909891A EP0432199B2 (en) 1988-09-02 1989-09-01 Composition for the treatment of erectile dysfunction
JP1509519A JPH0791199B2 (ja) 1988-09-02 1989-09-01 勃起機能障害の治療用組成物
CA000610172A CA1335346C (en) 1988-09-02 1989-09-01 Method of treating erectile dysfunction
FI910976A FI102454B (sv) 1988-09-02 1991-02-27 Förfarande för framställning av en komposition för behandling av erekt il funktionsstörning
NO910828A NO301046B1 (no) 1988-09-02 1991-03-01 Fremgangsmåte for fremstilling av preparat for behandling av erektil funksjonssvikt
DK199100364A DK175560B1 (da) 1988-09-02 1991-03-01 Præparat til behandling af erektiv dysfunktion
GR90300093T GR900300093T1 (en) 1988-09-02 1991-09-27 Composition for the treatment of erectile dysfunction
US08/478,982 US5849803A (en) 1988-09-02 1995-06-07 Method of treating erectile dysfunction with nitroglycerine
US08/485,041 US5886039A (en) 1988-09-02 1995-06-07 Method and composition for treating erectile dysfunction
US08/481,609 US5942512A (en) 1988-09-02 1995-06-07 Method and composition for treating erectile dysfunction
US08/484,546 US5843961A (en) 1988-09-02 1995-06-07 Method and composition for treating erectile dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803087A SE463851B (sv) 1988-09-02 1988-09-02 Komposition foer behandling av erektil dysfunktion via uretra

Publications (3)

Publication Number Publication Date
SE8803087D0 true SE8803087D0 (sv) 1988-09-02
SE8803087L SE8803087L (sv) 1990-03-03
SE463851B SE463851B (sv) 1991-02-04

Family

ID=20373202

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803087A SE463851B (sv) 1988-09-02 1988-09-02 Komposition foer behandling av erektil dysfunktion via uretra

Country Status (16)

Country Link
US (4) US5843961A (sv)
EP (2) EP0357581B2 (sv)
JP (1) JPH0791199B2 (sv)
AU (1) AU638414B2 (sv)
CA (1) CA1335346C (sv)
DE (1) DE68907909T3 (sv)
DK (1) DK175560B1 (sv)
ES (1) ES2055677T5 (sv)
FI (1) FI102454B (sv)
GR (1) GR900300093T1 (sv)
IE (1) IE62587B1 (sv)
NO (1) NO301046B1 (sv)
NZ (1) NZ230400A (sv)
SE (1) SE463851B (sv)
WO (1) WO1990002545A1 (sv)
ZA (1) ZA896681B (sv)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
ZA912984B (en) * 1990-04-25 1992-01-29 Alza Corp Treatment of erectile dysfunction
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US5503973A (en) * 1992-05-29 1996-04-02 The Regents Of The University Of California Method for inhibition of viral morphogenesis
US20030181355A1 (en) * 1992-05-29 2003-09-25 Glenn Jeffrey S. Method for inhibition of viral infection
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
CZ278497A3 (cs) * 1995-03-14 1998-04-15 Vivus, Incorporated Způsob a sestava zařízení k prevenci impotence
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
GB9608408D0 (en) * 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
IT1292377B1 (it) * 1997-06-19 1999-02-08 Nicox Sa Composizioni farmaceutiche a base di prostaglandine
IT1292426B1 (it) 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US5954688A (en) * 1997-08-26 1999-09-21 Queen's University At Kingston Everting toroid device for delivering a drug into a body cavity
US6200288B1 (en) 1997-08-26 2001-03-13 Queen's University At Kingston Everting toroid device for insertion into a body cavity
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
CN1282249A (zh) * 1997-12-18 2001-01-31 内森·厄尔·斯科特 用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂
WO1999047923A2 (en) 1998-03-20 1999-09-23 The Rockefeller University Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6194433B1 (en) 1998-10-05 2001-02-27 Neal R. Cutler Sexual dysfunction in females
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6132753A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6110489A (en) * 1998-05-01 2000-08-29 Cutler; Neal R. Use of quinolines and quinolones to treat male erectile dysfunction
US6132757A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
US6365590B1 (en) 1998-05-26 2002-04-02 Saint Louis University Compounds, compositions and methods for treating erectile dysfunction
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6482426B1 (en) 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
AU1414200A (en) * 1998-12-02 2000-06-19 Mochida Pharmaceutical Co., Ltd. Preparations for intraurethral administration
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US7176238B1 (en) 1999-03-01 2007-02-13 Nitromed Inc. Nitrostated and nitrosylated prostaglandins, compositions and methods of use
EP1173167A4 (en) 1999-04-30 2004-07-14 Lilly Icos Llc TREATMENT OF FEMALE SEXUAL STIMULATION DISORDERS
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
WO2004028444A2 (en) * 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
AUPQ105799A0 (en) 1999-06-18 1999-07-08 Victor Chang Cardiac Research Institute, The Cell growth inhibition
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2002007757A2 (en) * 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
EP1404336A1 (en) * 2001-06-14 2004-04-07 Sampad Bhattacharya Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
CN1203055C (zh) 2001-09-26 2005-05-25 朱德煦 治疗或预防细菌感染的方法和组合物
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
DK1572169T3 (da) * 2002-03-08 2013-10-21 Shanghai Inst Biol Sciences Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf
CA2480099C (en) 2002-03-26 2019-01-08 Zensun (Shanghai) Sci-Tech. Ltd. Erbb3 based methods and compositions for treating neoplasms
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
WO2003099320A1 (en) 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
KR20040043996A (ko) * 2002-11-20 2004-05-27 조나겐, 아이엔씨. 남성 발기부전치료를 위한 개선된 조성물
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
WO2010054321A2 (en) 2008-11-07 2010-05-14 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
AU2010318637A1 (en) 2009-10-13 2012-05-31 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
WO2011059586A2 (en) 2009-10-30 2011-05-19 The Regents Of The University Of Michigan Multifunctional small molecules
CN103228782B (zh) 2010-06-13 2016-03-30 中国科学院生物物理研究所 由干细胞制备心肌细胞的方法和组合物及其用途
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
US9402911B2 (en) 2011-12-08 2016-08-02 The Regents Of The University Of Michigan Multifunctional small molecules
AU2013295940B2 (en) 2012-07-23 2019-01-31 Institute Of Biophysics, Chinese Academy Of Sciences Method for inducing pluripotent stem cells to differentiate into ventricular myocytes in vitro
AU2012392119B2 (en) 2012-10-08 2018-07-26 Zensun (Shanghai) Science & Technology, Co. Ltd. Compositions and methods for treating heart failure in diabetic patients
KR102578135B1 (ko) 2013-05-22 2023-09-13 젠순 (상하이) 사이언스 앤드 테크놀로지 캄파니 리미티드 심부전을 치료하기 위한 뉴레귤린의 연장 방출
CN113289002A (zh) 2020-02-24 2021-08-24 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
CA1188987A (en) * 1981-03-06 1985-06-18 Masataka Morishita Preparation having excellent absorption property
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0149254A3 (en) * 1983-12-29 1987-01-28 The Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing l-histidine
DE3637157A1 (de) * 1985-11-01 1987-05-21 Byk Gulden Lomberg Chem Fab Arzneimittel zur behandlung erektiler dysfunktionen
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
DE3913954A1 (de) * 1989-04-27 1990-10-31 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
US5583144A (en) * 1995-02-24 1996-12-10 Kral; John G. Methods for treating erectile impotence

Also Published As

Publication number Publication date
EP0357581B2 (en) 1998-09-16
DK36491A (da) 1991-03-01
CA1335346C (en) 1995-04-25
ES2055677T3 (es) 1994-11-01
SE8803087L (sv) 1990-03-03
DK36491D0 (da) 1991-03-01
ES2055677T5 (es) 1998-11-16
US5849803A (en) 1998-12-15
DE68907909T2 (de) 1993-12-23
DE68907909T3 (de) 2004-02-26
EP0357581A1 (en) 1990-03-07
JPH04501707A (ja) 1992-03-26
AU638414B2 (en) 1993-07-01
US5942512A (en) 1999-08-24
DK175560B1 (da) 2004-12-06
NO910828D0 (no) 1991-03-01
EP0432199B1 (en) 1993-07-28
US5886039A (en) 1999-03-23
NZ230400A (en) 1992-01-29
DE68907909D1 (de) 1993-09-02
FI910976A0 (fi) 1991-02-27
ZA896681B (en) 1990-06-27
FI102454B1 (sv) 1998-12-15
AU4199489A (en) 1990-04-02
JPH0791199B2 (ja) 1995-10-04
US5843961A (en) 1998-12-01
EP0357581B1 (en) 1993-07-28
NO301046B1 (no) 1997-09-08
NO910828L (no) 1991-04-30
SE463851B (sv) 1991-02-04
ES2055677T1 (es) 1994-09-01
EP0432199A1 (en) 1991-06-19
IE62587B1 (en) 1995-02-08
IE892680L (en) 1990-03-02
FI102454B (sv) 1998-12-15
WO1990002545A1 (en) 1990-03-22
EP0432199B2 (en) 2003-07-30
GR900300093T1 (en) 1991-09-27

Similar Documents

Publication Publication Date Title
SE8803087D0 (sv) A new method of treating erectile dysfunction
SE8803486D0 (sv) Dosage form for treating cardiovascular diseases
DE782855T1 (de) Antiinflammatorische wirkstoffe zur aüsserlichen anwendung
ATE110578T1 (de) Von hydrogel angetriebene verabreichungsvorrichtung.
LV12452A (lv) Aktivas vielas vaginala ievadisanas sistema
FI903213A0 (fi) Foer transdermal administration avsett gestoden innehaollande medel.
ATE290836T1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
EP0489108A4 (en) Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
DE69013797D1 (de) Gehirnspezifische Zubereitung mit gesteuerter Abgabe.
TR28970A (tr) Makrosiklik laktonlar, hazirlanmalarina mahsus usul ve zararlilarin kontrolünde kullanimlari.
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
DE69002034D1 (de) Vorrichtung mit gesteuerter wirkstoffabgabe.
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
DK0391185T3 (da) 1,8-Naphthyridiner
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
DE68914951T3 (de) Urethralkatheter und dessen Herstellungsverfahren.
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
DE69718541T2 (de) Veterinäre Zusammensetzungen mit antibakteriellen Mitteln zur intramammären Anwendung
EP0539516A4 (sv)
DE58902867D1 (de) Radioaktiv markierte benzodiazepinderivate.
KR900012622A (ko) 피부질환치료 조성물
IT1229886B (it) Struttura di cassone chiuso per autocarri, rimorchi e simili.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8803087-9

Format of ref document f/p: F

NUG Patent has lapsed